Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (184)
  • Open Access

    ARTICLE

    GDF11 downregulates FOXP3 in T-cell acute lymphoblastic leukemia-derived cells and associates with restraining aggressiveness

    MELISSA SáNCHEZ-RODRíGUEZ1,2, ROBERTO LAZZARINI-LECHUGA3, VERóNICA SOUZA-ARROYO1,4, LETICIA BUCIO-ORTIZ1,4, ROXANA U. MIRANDA-LABRA1,4, MONSERRAT GERARDO-RAMíREZ1, ARACELI PáEZ-ARENAS5, MOISES VERGARA-MENDOZA6, MARíA CONCEPCIóN GUTIéRREZ-RUIZ1,4, ALEJANDRO ESCOBEDO-CALVARIO1,2,*, LUIS E. GOMEZ-QUIROZ1,4,*

    Oncology Research, Vol.33, No.8, pp. 2075-2084, 2025, DOI:10.32604/or.2025.064899 - 18 July 2025

    Abstract Background: Growth differentiation factor 11 (GDF11), a transforming growth factor-beta superfamily member, is a crucial protein involved in many differentiation processes in embryogenesis and morphogenesis, and it has been extensively characterized due to its capacity to target poorly differentiated cells, including transformed or cancer cells. Aim: In the present work, we aimed to describe the effects on migration, proliferation, and metabolism in the T-cell acute lymphoblastic leukemia-derived cell line Jurkat. Methods: Based on previous evidence, we analyzed metabolic changes exerted by GDF11 and its relationship with the aggressive phenotype. Results: We found a profound impact on More >

  • Open Access

    ARTICLE

    Rare Primary Diffuse Large B-Cell Lymphoma Confined to Bone Marrow: Features and Prognosis

    Weiwei Chen1, Xiaodie Zhou2, Huiyu Li1, Yuchen Yang1, Lu Lu1, Chunyan Zhu1, Rong Fang1, Xiaoyuan Chu1, Shuping Zhou3,*, Qian Sun1,*

    Oncology Research, Vol.33, No.8, pp. 2123-2139, 2025, DOI:10.32604/or.2025.063484 - 18 July 2025

    Abstract Background: Primary bone marrow diffuse large B-cell lymphoma (PBM-DLBCL) represents an uncommon yet clinically aggressive hematologic malignancy. Despite its significant clinical impact, this entity lacks standardized diagnostic criteria in current WHO classifications. Methods: We performed a retrospective analysis of 55 PBM-DLBCL cases from our institutional database and published literature (2001–2022) to characterize disease features and identify prognostic factors, with particular focus on assessing how different treatment regimens influence therapeutic efficacy and long-term outcomes. Results: The data suggested a potential link between international prognostic index (IPI) scores and poorer survival, albeit without conclusive statistical evidence (p = More >

  • Open Access

    REVIEW

    Research review of the mechanism and clinical application prospects of tertiary lymphoid structures in the immune micro-environment of gastrointestinal tumors

    JIANG ZHU*

    Oncology Research, Vol.33, No.7, pp. 1571-1580, 2025, DOI:10.32604/or.2025.058957 - 26 June 2025

    Abstract Changes in the intestinal immune micro-environment of the gastrointestinal tract are indispensable in the occurrence and development of gastrointestinal cancer. Tertiary lymphoid structure (TLS) is an immune cell aggregation structure found around gastrointestinal cancer in recent years. More and more research proves that tertiary lymphoid structure plays a key biological role and clinical value in disease progression, patient prognosis, and adjuvant treatment. This review aims to explore the research progress, biological significance, and potential clinical applications of TLSs in gastrointestinal tumors. The formation, development, and interaction of TLSs with tumor microenvironment have been reviewed and More >

  • Open Access

    ARTICLE

    Robotic-assisted super-extended pelvic lymph node dissection for prostate cancer: safety and pathologic findings

    Ryan Daigle1, Ilene Staff2, Joseph Tortora2, Tara McLaughlin Proto3,*, Kevin Pinto3, Rosa Negron2, Jonathan Earle4, Joseph Wagner,3

    Canadian Journal of Urology, Vol.32, No.3, pp. 189-198, 2025, DOI:10.32604/cju.2025.063773 - 27 June 2025

    Abstract Introduction: We examined the pathology and safety outcomes associated with the extent of pelvic lymph node dissection in patients with high-risk prostate cancer undergoing radical prostatectomy. Materials and Methods: We retrospectively identified men with prostate cancer who underwent robot-assisted radical prostatectomy with pelvic lymph node dissection between May 2016 and September 2021. Cases were categorized using Current Procedural Terminology (CPT) codes (38571) for extended lymph node dissection and super-extended lymph node dissection (38572). Using logistic regression, we compared the groups on a number of factors, including recurrence. Results: Super-extended lymph node dissection had significantly higher median… More >

  • Open Access

    ARTICLE

    Butyrophilin Downregulation in Chronic Lymphocytic Leukaemia: An Important Barrier to γδ T Cell-Mediated Cytotoxicity

    Natalia Lehman, Agnieszka Bojarska-Junak, Michał Zarobkiewicz*

    BIOCELL, Vol.49, No.6, pp. 1085-1099, 2025, DOI:10.32604/biocell.2025.063960 - 24 June 2025

    Abstract Introduction: Butyrophilins (BTNs) belong to the immunoglobulin superfamily; they play crucial roles in immune regulation, especially in γδ T cell activation. While their expression has been studied in solid tumours, their involvement in hematologic malignancies remains poorly understood. Objectives: We hypothesised that BTNs are dysregulated in chronic lymphocytic leukaemia (CLL), contributing to γδ T cell dysfunction and potentially influencing disease progression. Methods: In this study, we analyzed publicly available microarray and RNA-seq datasets to investigate the expression patterns of BTN genes in CLL. Results: Our findings reveal significant dysregulation of BTN gene expression in CLL, with BTN2A1, BTN3A1, BTN3A2,… More >

  • Open Access

    ARTICLE

    Optimized Feature Selection for Leukemia Diagnosis Using Frog-Snake Optimization and Deep Learning Integration

    Reza Goodarzi1, Ali Jalali1,*, Omid Hashemi Pour Tafreshi1, Jalil Mazloum1, Peyman Beygi2

    CMC-Computers, Materials & Continua, Vol.84, No.1, pp. 653-679, 2025, DOI:10.32604/cmc.2025.062803 - 09 June 2025

    Abstract Acute lymphoblastic leukemia (ALL) is characterized by overgrowth of immature lymphoid cells in the bone marrow at the expense of normal hematopoiesis. One of the most prioritized tasks is the early and correct diagnosis of this malignancy; however, manual observation of the blood smear is very time-consuming and requires labor and expertise. Transfer learning in deep neural networks is of growing importance to intricate medical tasks such as medical imaging. Our work proposes an application of a novel ensemble architecture that puts together Vision Transformer and EfficientNetV2. This approach fuses deep and spatial features to… More >

  • Open Access

    REVIEW

    Advances and challenges in leukemia treatment: A focus on monoclonal antibodies and emerging therapies

    GIOVANA GOMES CHAGAS1, RUAN PIMENTA2, NAYARA IZABEL VIANA1,*

    Oncology Research, Vol.33, No.6, pp. 1283-1288, 2025, DOI:10.32604/or.2025.055100 - 29 May 2025

    Abstract The monoclonal antibodies consist of an innovative form of immunotherapy, capable of defeating several diseases, such as cancer. It is an emergent and important theme, that advances evaluation, challenges, and future perspectives with high relevance to identify gaps in recent studies and to consolidate this general theme in only one research. Its action in Chronic and Acute Lymphoid Leukemia has been evaluated in several clinical trials, which were selected between 2022 and 2023, in order to understand better the monoclonal antibodies that were most studied. The biopharmaceutical compounds Ibrutinib, Obinutuzumab, Rituximab, Venetoclax, and Inotuzumab Ozogamicin… More >

  • Open Access

    ARTICLE

    Characterization of Transcription Factor Krüppel-Like Factor 3 Expression in Splenic T Lymphocytes and Association with Immune Status in Septic Mice

    MIAO YAN1, DONGXUAN CHI2, WEN WANG3, PEI PEI4, MIN XIE1, SHUANGLING LI1,*

    BIOCELL, Vol.49, No.5, pp. 893-906, 2025, DOI:10.32604/biocell.2025.063622 - 27 May 2025

    Abstract Background: Transcription factor Krüppel-like factor 3 (KLF3) may be involved in regulating inflammation and lymphocyte function. Immune dysfunction in sepsis involves both hyper-inflammation and immunosuppression. However, studies on T-lymphocyte KLF3 expression in sepsis are lacking. Methods: We induced sepsis in mice via cecal ligation and puncture (CLP), and their survival rate over 7 days was evaluated. To identify the immune status of these mice, we assessed their cytokine levels, organ damage scores, and splenic T-lymphocyte phenotype. Finally, T-lymphocyte KLF3 expression was detected through flow cytometry. Results: Over the 7 days of observation, septic mice demonstrated 64.7%… More >

  • Open Access

    ARTICLE

    Hyperthyroidism-Induced Lymphoid Cell Activation in the Lymph Nodes and Spleen of BALB/c Mice

    María Belén Rocco, Clara Requena D’Alessio, Valeria Giselle Sánchez, Horacio Eduardo Romeo, María Laura Barreiro Arcos*

    BIOCELL, Vol.49, No.4, pp. 629-646, 2025, DOI:10.32604/biocell.2025.062525 - 30 April 2025

    Abstract Introduction: Hyperthyroidism is known to affect various physiological systems, including the immune system. Thyroid hormones (THs) play a crucial role in regulating immune function, and alterations in THs levels can lead to immune dysregulation. Objective: Currently, we aimed to elucidate the effects of hyperthyroidism on immune function in BALB/c mice, with a focus on anatomical and histological changes in lymphoid organs, the immune response to mitogenic stimulation, mitochondrial dynamics, and reactive oxygen species (ROS) production. Methods: Hyperthyroidism was induced in BALB/c mice by administering thyroxine (T4; 14 mg/L) in their drinking water for 30 days. Thyroid… More >

  • Open Access

    ARTICLE

    Mycobacterial antigen Ag85B restrains Hodgkin lymphoma tumor growth by inhibiting autophagy

    YONGFENG CHENG1, YIPING SHEN2, YUNFEI ZHANG1, HAILIQIGULI NURIDING1, XUEMEI WANG1, CHUNYAN FAN1, GULIBAHA MAIMAITI1, YU LIU1, YINGBIN YUE1, DANLU LI1, MEI YAN1,*

    Oncology Research, Vol.33, No.5, pp. 1173-1187, 2025, DOI:10.32604/or.2025.057842 - 18 April 2025

    Abstract Background: The growth of the B-cell lymphoma subtype, Hodgkin lymphoma (HL), is associated with increased autophagy. A mycobacterial antigen, Ag85, has been reported to inhibit cell autophagy under a variety of conditions. Whether Ag85 could inhibit autophagy in HL is unknown. Methods: Lymph node samples from patients with HL and healthy controls were collected to assess proliferation and autophagy. The human HL cell line, L-428, was cultured and subjected to Ag85B treatment. Autophagy in L-428 cells was evaluated through western blotting analysis, immunohistochemistry, and transmission electron microscopy. Apoptosis in these cells was measured using flow… More >

Displaying 31-40 on page 4 of 184. Per Page